![Brendan Hannah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brendan Hannah
No open positions remaining
Net worth: 56 097 $ as of 30/09/2026
Profile
Mr. Brendan Hannah was previously employed as a COO, Chief Business & Compliance Officer by Quince Therapeutics, Inc., a Chief Operating Officer by Novosteo, Inc., a Chief Business Officer by Neuroptika, Inc., a Head-Corporate Development by Agenovir Corp., a Vice President-Operations & Strategy by Geom Therapeutics, Inc., and a Director-Business Development by Cidara Therapeutics, Inc. He received his undergraduate degree from The Colorado College and an MBA from Anderson School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/07/2026 | 1,809 ( 0.02% ) | 56 097 $ | 30/09/2026 |
Former positions of Brendan Hannah
| Companies | Position | End |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Director of Finance/CFO | 08/10/2026 |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Chief Operating Officer | 01/05/2022 |
Neuroptika, Inc.
 Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company which develops drugs for eye diseases and nerves regeneration | Corporate Officer/Principal | 01/10/2021 |
Geom Therapeutics, Inc.
 Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Corporate Officer/Principal | 01/03/2020 |
Agenovir Corp.
 Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Corporate Officer/Principal | 01/01/2018 |
Education of Brendan Hannah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
27
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
The Colorado College
 The Colorado College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Anderson School of Management
 Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Agenovir Corp.
Agenovir Corp. BiotechnologyHealth Technology Engages in research and development of human therapeutics for the treatment of diseases | Health Technology |
Geom Therapeutics, Inc.
Geom Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of antibiotic for MDR gram negative infections | Commercial Services |
Neuroptika, Inc.
Neuroptika, Inc. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company which develops drugs for eye diseases and nerves regeneration | Health Technology |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
- Stock Market
- Insiders
- Brendan Hannah
